Tilray Brands (TLRY) Cash & Current Investments (2017 - 2026)

Tilray Brands (TLRY) posted Cash & Current Investments of $60.2 million for Q1 2026, down 79.35% on a QoQ basis from $291.6 million in Q4 2025.

Tilray Brands (TLRY) Cash & Current Investments (2017 - 2026) Analysis & Trends

Tilray Brands' Cash & Current Investments history runs 10 years deep, the most recent figure standing at $60.2 million for Q1 2026.

  • Quarterly Cash & Current Investments changed N/A year-over-year to $60.2 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $60.2 million (changed N/A YoY) and the FY2025 annual result came in at $34.7 million, down 86.68% from the prior year.
  • Cash & Current Investments was $60.2 million for Q1 2026 at Tilray Brands, down from $291.6 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $490.6 million in Q3 2022 and bottomed at $34.7 million in Q2 2025.
  • A 5-year average of $271.4 million and a median of $262.7 million in 2024 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2024 — Cash & Current Investments soared 56.34% — and 2025, when it tumbled 86.68%.
  • Tilray Brands' Cash & Current Investments stood at $433.5 million in 2022, then plunged by 40.07% to $259.8 million in 2023, then dropped by 2.9% to $252.2 million in 2024, then grew by 15.58% to $291.6 million in 2025, then slumped by 79.35% to $60.2 million in 2026.
  • Business Quant data shows TLRY's Cash & Current Investments at $60.2 million in Q1 2026, $291.6 million in Q4 2025, and $264.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 89.60 Bn 87.73 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 35.91 Bn 32.16 Bn 1.97 Bn 3.74 Bn
3 Zoetis 32.46 Bn 30.52 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.56 Bn 23.49 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 23.13 Bn 20.98 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 21.80 Bn 21.80 Bn - -
7 Viatris 20.28 Bn 18.48 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.75 Bn 16.43 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.60 Bn 12.18 Bn 785.00 Mn 428.00 Mn
10 Tilray Brands 452.95 Mn 392.75 Mn 54.95 Mn 60.20 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 60.20 Mn
Nov 30, 2025 291.55 Mn
Aug 31, 2025 264.83 Mn
May 31, 2025 34.70 Mn
Nov 30, 2024 252.25 Mn
Aug 31, 2024 280.06 Mn
May 31, 2024 260.52 Mn
Feb 29, 2024 225.86 Mn
Nov 30, 2023 259.79 Mn
Aug 31, 2023 179.13 Mn
May 31, 2023 206.63 Mn
Feb 28, 2023 408.28 Mn
Nov 30, 2022 433.50 Mn
Aug 31, 2022 490.64 Mn
May 31, 2022 415.91 Mn
Feb 28, 2022 279.21 Mn
Nov 30, 2021 331.78 Mn
Aug 31, 2021 376.30 Mn
May 31, 2021 488.47 Mn
May 31, 2020 360.65 Mn